Featured Research

from universities, journals, and other organizations

Hormone Therapy Offers New Hope For Ovarian Cancer Patients

Date:
June 17, 2007
Source:
University of Edinburgh
Summary:
Researchers have shown that the use of anti-estrogen drugs can extend life in ovarian cancer patients by up to three years. Hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy.

Researchers at the University of Edinburgh have shown that hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy.

Related Articles


The study, published in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-estrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

Letrozole hormone therapy -- already used with great success in the treatment of breast tumours - attacks cancer by turning off its estrogen supply. But scientists now believe that in those ovarian cancers which are highly sensitive to estrogen, this blocking mechanism could slow the growth and spread of disease.

The study was funded by Cancer Research UK and involved 44 women with high estrogen receptor (ER) levels, whose cancer had relapsed after surgery and chemotherapy.

Scientists used a blood-borne tumour marker, CA-125, to track the progress of tumours during hormone treatment. They discovered that one quarter of the women showed no tumour growth after six months of anti-estrogen therapy, and 33 per cent of the group with the greatest ER values showed a positive response which delayed the use of chemotherapy.

John F. Smyth, Professor of Medical Oncology at the University of Edinburgh, led the research programme.

He said: "This is an important landmark in the research and treatment of ovarian cancer. Despite intense scientific research over the past 20 years, there have been few new leads in our understanding of how this disease operates. But this study suggests that the addition of hormone therapy to our treatment strategy could extend and improve the lives of women with cancer."

Ovarian cancer is the most commonly fatal of gynaecological cancers, affecting 1 in 48 women. Nearly 7,000 new cases are diagnosed in the UK each year.

Current treatment involves surgery and chemotherapy, but most ovarian cancers return within two years. Until now, further treatment options have been limited to a second course of chemotherapy, with serious implications for quality of life. It is hoped hormone treatment could offer life-extension with negligible side effects.

Dr Simon Langdon, senior lecturer in cancer research at the University of Edinburgh and the lead scientist behind this trial, said: "Ovarian cancer can be a devastating disease, so this new discovery is particularly exciting. We still have a lot to do, but this research has furthered our understanding of the hormone control of ovarian cancer, which could provide less grueling treatments for cancer patients. It presents new possibilities for tailor-made cancer therapy and demands further investigation."


Story Source:

The above story is based on materials provided by University of Edinburgh. Note: Materials may be edited for content and length.


Cite This Page:

University of Edinburgh. "Hormone Therapy Offers New Hope For Ovarian Cancer Patients." ScienceDaily. ScienceDaily, 17 June 2007. <www.sciencedaily.com/releases/2007/06/070615075557.htm>.
University of Edinburgh. (2007, June 17). Hormone Therapy Offers New Hope For Ovarian Cancer Patients. ScienceDaily. Retrieved January 26, 2015 from www.sciencedaily.com/releases/2007/06/070615075557.htm
University of Edinburgh. "Hormone Therapy Offers New Hope For Ovarian Cancer Patients." ScienceDaily. www.sciencedaily.com/releases/2007/06/070615075557.htm (accessed January 26, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, January 26, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Mistakes Should Serve a Lesson Says WHO

Ebola Mistakes Should Serve a Lesson Says WHO

AFP (Jan. 25, 2015) The World Health Organization&apos;s chief on Sunday admitted the UN agency had been caught napping on Ebola, saying it should serve a lesson to avoid similar mistakes in future. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Disneyland Measles Outbreak Spreads To 5 States

Disneyland Measles Outbreak Spreads To 5 States

Newsy (Jan. 24, 2015) Much of the Disneyland measles outbreak is being blamed on the anti-vaccination movement. The CDC encourages just about everyone get immunized. Video provided by Newsy
Powered by NewsLook.com
Growing Measles Outbreak Worries Calif. Parents

Growing Measles Outbreak Worries Calif. Parents

AP (Jan. 23, 2015) Public health officials are rushing to contain a measles outbreak that has sickened 70 people across 6 states and Mexico. The AP&apos;s Raquel Maria Dillon has more. (Jan. 23) Video provided by AP
Powered by NewsLook.com
Smart Wristband to Shock Away Bad Habits

Smart Wristband to Shock Away Bad Habits

Reuters - Innovations Video Online (Jan. 23, 2015) A Boston start-up is developing a wristband they say will help users break bad habits by jolting them with an electric shock. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins